NFE2L2

Chr 2AD

NFE2 like bZIP transcription factor 2

Also known as: IMDDHH, NRF2, Nrf-2

This gene encodes a transcription factor which is a member of a small family of basic leucine zipper (bZIP) proteins. The encoded transcription factor regulates genes which contain antioxidant response elements (ARE) in their promoters; many of these genes encode proteins involved in response to injury and inflammation which includes the production of free radicals. Multiple transcript variants encoding different isoforms have been characterized for this gene. [provided by RefSeq, Sep 2015]

OMIMResearchGenerating clinical summary…
GOFmechanismADLOEUF 0.661 OMIM phenotype
Clinical SummaryNFE2L2
🧬
Gene-Disease Validity (ClinGen)
immunodeficiency, developmental delay, and hypohomocysteinemia · ADLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
5 unique Pathogenic / Likely Pathogenic· 229 VUS of 427 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.66LOEUF
pLI 0.004
Z-score 2.74
OE 0.37 (0.210.66)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.21Z-score
OE missense 0.81 (0.730.90)
252 obs / 312.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.37 (0.210.66)
00.351.4
Missense OE?0.81 (0.730.90)
00.61.4
Synonymous OE?0.90
01.21.6
LoF obs/exp: 8 / 21.8Missense obs/exp: 252 / 312.1Syn Z: 0.84
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongNFE2L2-related leukoencephalopathy, immune deficiency and hypohomocysteinaemiaGOFAD

This gene — mechanism propensity

DN
0.5868th %ile
GOF
0.3986th %ile
LOF
0.4528th %ile

The Badonyi & Marsh model scores dominant-negative highest, but genomic evidence most strongly supports gain-of-function as the primary mechanism.

GOF1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFOverall, the findings suggested that the mutations increased NFE2L2 levels in the absence of stress and caused constitutive chronic activation of stress response genes, consistent with a gain-of-function effect.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 29018201

ClinVar Variant Classifications

427 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic2
VUS229
Likely Benign137
Benign33
Conflicting13
3
Pathogenic
2
Likely Pathogenic
229
VUS
137
Likely Benign
33
Benign
13
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
3
0
0
3
Likely Pathogenic
0
2
0
0
2
VUS
22
204
3
0
229
Likely Benign
2
15
21
99
137
Benign
0
26
4
3
33
Conflicting
13
Total2425028102417

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

30 pathogenic / likely-pathogenic (of 36) ClinVar copy-number / structural variants overlap NFE2L2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

NFE2L2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.